Indie Health

Indie Health is a digital health company that provides a "Device-as-a-Service" platform designed to simplify remote patient monitoring (RPM). The company offers a unified API and cloud-based infrastructure that allows healthcare providers and digital health app developers to integrate a wide variety of connected medical devices seamlessly. By managing device logistics, data connectivity, and regulatory requirements, Indie Health enables the scaling of remote care programs for chronic conditions like diabetes and hypertension. In 2021, the company was acquired by LifeScan, a global leader in blood glucose monitoring, to enhance its digital health ecosystem. The platform continues to serve as a critical bridge between medical hardware and digital health software solutions.